Lilly Inks Follow-Up Radiopharmaceuticals Deal With Aktis

 
• By Jessica Merrill

The big pharma will pay $60m upfront and make an equity investment in the Boston-based startup.

Radiopharmaceuticals deal-making continues • Source: Shutterstock

More from Deals

More from Business